HC Banking to Large Pharma/Biotech back to HC Banking/PE
Here is an idea that I have been throwing around lately. Currently, I'm a first year analyst at a boutique investment bank. My group is focused on healthcare/biotech, which I love. I'm curious to see if anyone has made the transition from banking to a finance related position (or another position) within a fortune 100 company, it doesn't have to be HC related. I have some really solid connections at Big Pharma/Big Biotech that I know would give me a position relating to finance within their organization, potentially on their internal M&A team.
I say this because I think it would be a great experience for when I go to apply to b-school. I also think it would give me credibility coming out of b-school, should I want to jump into a HC focused PE shop. I think industry experience at the corporate level would provide significant value when returning to HC focused Banking/PE.
Also, if you believe it would be more valuable to take on a position outside of the finance realm within a F100 please state your opinion.
Thank you so much for the feedback.
I would love to hear comments about this too. I will be starting as a first year analyst in a BB healthcare group, and I'm thinking 2-3 years IB, 2 years biotech PE/VC and then corporate M&A in Big Pharma/Biotech.
Qui voluptatem ducimus architecto cupiditate. Praesentium corporis dolorem reprehenderit in repellat corporis est minus. Nihil dolor aut dicta voluptatum quia molestias. Quasi aut quis delectus ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...